Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2005-03-04
2010-06-01
Angell, J. E (Department: 1635)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
Reexamination Certificate
active
07727970
ABSTRACT:
The present invention provides multiple-promoter expression cassettes for simultaneous delivery of RNAi, preferably to mammalian cells in vivo.
REFERENCES:
patent: 5585258 (1996-12-01), Houghton et al.
patent: 6127116 (2000-10-01), Rice et al.
patent: 6472180 (2002-10-01), Houghton et al.
patent: 2004/0053876 (2004-03-01), Turner et al.
patent: 2 468 955 (2003-06-01), None
patent: 2 479 409 (2003-09-01), None
patent: 1611606 (2005-05-01), None
patent: WO 99/49029 (1999-09-01), None
patent: WO 01/83736 (2001-11-01), None
patent: WO 03/016572 (2003-02-01), None
patent: WO 03/070750 (2003-08-01), None
patent: WO 03/078629 (2003-09-01), None
patent: WO 03/079757 (2003-10-01), None
patent: WO 2004/011647 (2004-02-01), None
PCT International Search Report for PCT/US2005/007447, dated Jan. 3, 2006.
Blight, et al. “Efficient Initiation of HCV RNA Replication in Cell Culture,”Science. 290:1972-74 (2000), pp. 1972-1974.
Boden, et al., “Human Immunodeficiency Virus Type 1 Escape from RNA Interface,”J. Virol. 77(21), (2003), pp. 11531-11535.
Cavazzana-Calvo, et al., “Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease,”Science, 288:669-72 (2000), pp. 669-672.
Chen, et al., “Minicircle DNA Vectors Devoid of Bacterial DNA Result in Persistent and High-Level Transgene Expression in Vivo,”Molecular Therapy8(3): (2003), pp. 495-500.
Domitrovich, et al., “Multiple, Dispersed Human U6 Small Nuclear RNA Genes with Varied Transcriptional Efficiencies,”Nucl. Acids Res. 31(9): pp. 2344-2352 (2003).
Elbashir, et al., “Functional Anatomy of siRNAs for Mediating Efficient RNAi inDrosophila melanogasterEmbryo lysate,”Embo. J. 20(23): (2001) pp. 6877-6888.
Elbashir, et al., “Duplexes of 21-Nucleotide RNAs Mediate RNA Interface in Cultured Mammalian Cells,”Nature, 411:494-498 (2001).
Fire, et al., “Potent and Specific Genetic Interference by Double-Stranded RNA inCaenorhabditis elegans,” Nature. 391:806-11 (1998).
Fu, et al., “Self-Complementary Adeno-Associated Virus Serotype 2 Vector: Global Distribution and Broad Dispersion of AAV-Mediated Transgene Expression in Mouse Brian,”Molec Therapy. 8(6): (2003) pp. 911-917.
Furth, et al., “Gene Transfer into Somatic Tissues by Jet Injection,”Anal Biochem115(205): (1992) pp. 365-368.
Gitlin, et al., “Short Interfering RNA Confers Intracellular Antiviral Immunity in Human Cells,”Nature. 418: (2002) pp. 430-434.
Grimm, et al., “Preclinical in vivo Evaluation of Pseudotyped Adeno-Associated Virus Vectors for Liver Gene Therapy,”Blood. (Oct. 2003) vol. 102, No. 7, pp. 2412-2419.
Guidotti, et al., “Noncytolytic Control of Viral Infections by the Innate and Adaptive Immune Response,”Annu. Rev. Immunol, 19 (2001) pp. 65-91.
Harborth, et al., “Sequence, Chemical, and Structural Variation of Small Interfering RNAs and Short Hairpin RNAs and the Effect of Mammalian Gene Silencing,”Antisense Nucleic Acid Drug Rev., 13(2): (2003) pp. 83-105.
Higashibata, et al., “Identfication of Promoter Regions Involved in Cell- and Developmental Stage-Specific Osteopontin Expression in Bone, Kidney, Placenta, and Mammary Gland: An Analyis of Transgenic Mice,”Bone Miner. Res., Jan. 19(1): (2004) pp. 78-88.
Hoggatt, et al., “Cell-Specific Regulatory Modules Control Expression of Genes in Vascular and Visceral Smooth Muscle Tissues,”Cir. Res. Dec. 91(12): (2002) pp. 1151-1159.
Kay, et al., “Looking into the Safety of AAV Vectors,”Nature424: (Jul. 2003) p. 251.
Klein, et al. “Inhibition of Hepatitis B Virus Replication in Vivo by Nucleoside Analogues and siRNA,”Gastroenterology125(1): (2003) pp. 9-18.
Kurreck, “Antisense Technologies: Improvement Through Novel Chemical Modifications,”Eur J. Bioch270: (2003) pp. 1628-1644.
Maraia, et al., “The Human Y4 Small Cytoplasmic RNA Gene is Controlled by Upstream Elements and Resides on Chromosome 7 With All Other hY scRNA Genes,”Nucleic Acids Res. 22(15): (1994) pp. 3045-3052.
Maraia, et al., “Gene Encoding Human Ro-Associated Autoantigen Y5 RNA,”Nucleic Acids Res. 24(18): (1994) pp. 3552-3559.
McCaffrey, et al. “RNA Interface in Adult Mice”Nature418: (2002) pp. 38-39.
McCaffrey, et al. “Inhibition of Hepatitis B Virus in Mice by RNA Interference,”Nature Biotech21(6): (Jun. 2003) pp. 639-644.
McCarty, et al., “Self-Complementary Recombinant Adeno-Associated Virus (scAAV) Vectors Promote Efficient Transduction Independently of DNA Synthesis,”Gene Therapy8: (2001) pp. 1248-1254.
Mingozzi, et al., “Improved Hepatic Gene Transfer by Using an Adeno-Associated Virus Serotype 5 Vector,”J. Virol. 76(20): (2002) pp. 10497-10502.
Nakai, et al., “A Limited Number of Transducible Hepatocytes Restricts a Wide-Range linear Vector Dose Response in Recombinant Adeno-Associated Virus-Mediated Liver Transduction,”J. Virol. 76: (2002) p. 11343-11349.
Perri, et al. “Replicon Vectors Derived from Sindbis Virus and Semliki Forest That Established Persistant Replication in Host Cells,”J. Virol74(20): (2002) pp. 9802-9807.
Sohal, et al., “Temporally Regulated and Tissue-Specific Gene Manipulations in the Adult and Embryonic Heart Using a Tamoxifen-Inducible Cre Protein,”Cir. Res. Jul 89(1): (2001) pp. 20-25.
Tang, et al. “Genetic Immunization is a Simple Method for Eliciting an Immune Response,”Nature, 356: (1992) pp. 452-154.
Thomas, et al. “Rapid Uncoating of Vector Genomes is the Key to Efficient Liver Transduction with Pseudotyped Adeno-Associated Virus Vectors,”J. Virol. 78(6): (2004) pp. 3110-3122.
Thomas, et al., “Progress and Problems with the Use of Viral Vectors for Gene Therapy,”Nature Reviews, Genetics 4: (May 2003) pp. 346-358.
Tomar, et al. “Use of Adeno-Associated Viral Vector for Deliver of Small Interfering RNA,”Oncogene. 22: (2003) pp. 5712-5715.
Tuschl, et al., “Targeted mRNA Degradation by Double-Stranded RNA in Vitro,”Genes&Dev., 13: (1999) pp. 3191-3197.
Xia, et al., “An Enhanced U6 Promoter for Synthesis of Short Hairpin RNA,”Nucleic Acids Res. 31(17) (2003), 5 pages.
Yant, et al., “Transposition from a Gutless Adeno-Transposon Vector Stabilizes Transgene Expression in Vivo,”Nature Biotech. 20: (2002) pp. 999-1004.
Ying, et al. “Selective Inhibition of Hepatitis B Virus Replication by RNA Interference,”Biochem. Biophys. Res. Commun. 309(2): (2003) pp. 482-484.
Yokota, et al. “Inhibition of Intracellular Hepatitis C Virus Replication by Synthetic and Vector-Derived Small Interfering RNAs,”EMBO Rep. 4(6): (2003) pp. 602-608.
Zhang, et al., “Multiple Variable First Exons: A Mechanism for Cell- and Tissue-Specific Gene Regulation,”Genome Res. Jan 14(1): (2004) pp. 79-89.
PCT International Search Report for PCT/US2005/007447, dated Oct. 17, 2005.
Yokota, et al., “Inhibition of Intracellular Hepatitis C Virus Replication by Synthetic and Vector-Derived Small Interfering RNA's,” EMBO Reports. vol. 4, No. 6 (2003), p. 602-608.
Miller, et al., “Allele-Specific Silencing of Dominant Disease Genes,” PNAS, Jun. 10, 2003, vol. 100, No. 12, p. 7195-7200.
Tomar, et al., “Use of Adeno-Associated Viral Vector for Delivery of Small Interfering RNA,” Oncogene (2003) p. 5712-5715.
Boden, et al., “Human Immunodeficiency Virus Type I Escape from RNA Interference,” Journal of Virology, Nov. 2003, p. 11531-11535.
Yin, Yet al., “The Potential Medical Application of RNAi Technology,”Foreign Medical Science: Section of Molecule Biology, 2003; 25(6):378-381. With English-language Abstract.
Kolykhalov Alexander A.
Roelvink Petrus W.
Suhy David A.
Angell J. E
Benitec, Inc.
Patton & Boggs LLP
LandOfFree
Multiple promoter expression cassettes for simultaneous... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Multiple promoter expression cassettes for simultaneous..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Multiple promoter expression cassettes for simultaneous... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4157965